Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh

BACKGROUND: AmBisome therapy for VL has an excellent efficacy and safety profile and has been adopted as a first-line regimen in Bangladesh. Second-line treatment options are limited and should preferably be given in short course combinations in order to prevent the development of resistant strains....

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Ridwanur, Goyal, Vishal, Haque, Rashidul, Jamil, Kazi, Faiz, Abul, Samad, Rasheda, Ellis, Sally, Balasegaram, Manica, den Boer, Margriet, Rijal, Suman, Strub-Wourgaft, Nathalie, Alves, Fabiana, Alvar, Jorge, Sharma, Bhawna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466346/
https://www.ncbi.nlm.nih.gov/pubmed/28558062
http://dx.doi.org/10.1371/journal.pntd.0005635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466346/
https://www.ncbi.nlm.nih.gov/pubmed/28558062
http://dx.doi.org/10.1371/journal.pntd.0005635

Ejemplares similares